Touchstone
Last syncNov 1, 2026, 6:55 PM ET

HCSG

Healthcare Services Group Inc Health Care Services-Nursing & Personal Care Facilities Russell 3000
$24.52Close $1.7BMarket cap $17.02 – $25.3152-week range Mid-januaryNext report · estimated

Highlights

Strengths

  • In a stage-2 uptrend all 8 trend conditions pass
  • Near its high 3% below its 52-week high

Cautions

  • Earnings shrinking EPS −39% year on year

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Oct 23, 2026
Off 12-month high 3%
1wk down 3.1% price change
1mo up 19.9% price change
12-month return up 34% market up 11% · its own up 20%
F-score 8 / 9 Exceptional
Altman Z″ 6.98 Low risk
P/E 28.9× price / earnings
PEG 0.56 P/E / EPS growth
P/B 3.3× price / book
Earnings yield up 4.3% EBIT / enterprise value
Cheaper than 64% of the market · cheap
Revenue growth up 7% year on year
EPS growth down 39% latest quarter
Sales growth up 3% latest quarter · +1 pts
ROE up 12% return on equity
Free cash margin up 8% $139.2M FCF
D/E — long-term debt / equity
Net debt / EBITDA -1.5× net cash
Interest cover —EBIT / interest
Piotroski tests
  • gross margin narrowed
  • profitable on its assets
  • generating cash from operations
  • profitability improving
  • profits backed by cash
  • reduced long-term debt
  • short-term liquidity improved
  • no new shares issued
  • assets working harder

Trade setup

ATR% 3.2% $0.80 a day · 2×ATR $22.93
RS 73 / 99 vs the universe
Trend 8 / 8 trend template
Relative volume 0.9× vs 50-day average
Up/down volume 0.84 50 sessions
Implied move — no scheduled report
Trend template · 8 of 8

Screen verdict

Did not qualify for any screen.

Warning signs

none flagged
  • No restatement or impairment
  • Equity positive
  • Interest covered
  • No material dilution
  • Profits tracking cash
  • Margins and revenue not shrinking
Last reported Oct 21, 2026
Results reaction Oct 21, 2026+16% vs market2 sessions after results

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $1.8B +7% on FY2024
$0 $2B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $1.8B FY2021 · $1.6B FY2022 · $1.7B FY2023 · $1.7B FY2024 · $1.7B FY2025 · $1.8B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $59.1M +50% on FY2024
$0 $100M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $98.7M FY2021 · $48.5M FY2022 · $34.2M FY2023 · $38.4M FY2024 · $39.5M FY2025 · $59.1M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $139.2M +469% on FY2024
$0 $250M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $212.9M FY2021 · $31.4M FY2022 · -$13.4M FY2023 · $38.1M FY2024 · $24.5M FY2025 · $139.2M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 13%
  • Net 3%
  • Free cash 8%
0% 20% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 15% · Net 6% · Free cash 12% FY2021 · Gross 14% · Net 3% · Free cash 2% FY2022 · Gross 11% · Net 2% · Free cash -1% FY2023 · Gross 13% · Net 2% · Free cash 2% FY2024 · Gross 13% · Net 2% · Free cash 1% FY2025 · Gross 13% · Net 3% · Free cash 8%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology
  • Cash
  • Long-term debt
$0 $200M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $139.3M FY2021 · Cash $70.8M FY2022 · Cash $26.3M FY2023 · Cash $54.3M FY2024 · Cash $56.8M FY2025 · Cash $125.2M
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 69.60m -6.6% since FY2020
74.48m 69.60m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 74.48m FY2021 · 73.77m FY2022 · 74.09m FY2023 · 73.34m FY2024 · 73.20m FY2025 · 69.60m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $1.8B $1.6B $1.7B $1.7B $1.7B $1.8B
Gross margin 15% 14% 11% 13% 13% 13%
Net income $98.7M $48.5M $34.2M $38.4M $39.5M $59.1M
Net margin 6% 3% 2% 2% 2% 3%
Earnings per share $1.32 $0.65 $0.46 $0.52 $0.53 $0.81
Free cash flow $212.9M $31.4M -$13.4M $38.1M $24.5M $139.2M
Free cash margin 12% 2% -1% 2% 1% 8%
Cash $139.3M $70.8M $26.3M $54.3M $56.8M $125.2M
Shareholders' equity $470.3M $445.2M $418.3M $456.6M $499.9M $510.2M
Shares outstanding 74.48m 73.77m 74.09m 73.34m 73.20m 69.60m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Oct 23, 2026 Quarterly ↗ Sep 30, 2026 23d
Jul 24, 2026 Quarterly ↗ Jun 30, 2026 24d
Apr 24, 2026 Quarterly ↗ Mar 31, 2026 24d
Feb 13, 2026 Annual ↗ Dec 31, 2025 44d
Oct 24, 2025 Quarterly ↗ Sep 30, 2025 24d
Jul 25, 2025 Quarterly ↗ Jun 30, 2025 25d
Apr 25, 2025 Quarterly ↗ Mar 31, 2025 25d
Feb 14, 2025 Annual ↗ Dec 31, 2024 45d
Oct 25, 2024 Quarterly ↗ Sep 30, 2024 25d
Jul 26, 2024 Quarterly ↗ Jun 30, 2024 26d
Apr 26, 2024 Quarterly ↗ Mar 31, 2024 26d
Feb 16, 2024 Annual ↗ Dec 31, 2023 47d

Current reports

FiledDisclosed
Oct 21, 2026 Results ↗
Oct 7, 2026 Material agreement · Regulation FD ↗
Jul 22, 2026 Results ↗
May 27, 2026 Shareholder vote ↗
Apr 22, 2026 Results ↗
Apr 13, 2026 Material agreement · New obligation ↗
Feb 11, 2026 Results ↗
Oct 22, 2025 Results ↗
Jul 23, 2025 Results ↗
Jul 10, 2025 Regulation FD ↗
May 28, 2025 Shareholder vote ↗
Apr 23, 2025 Results ↗